Metraipolis › archive › dc_df56ed40e5ab

Nafamostat mesilate attenuates renal fibrosis by suppressing the IL-17 signaling pathway — Europe PMC PMID:41244830

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41244830
DOI
10.3389/fphar.2025.1648623
License (as archived)
solo-consultazione
Archived
2026-11-08T21:49:20.990Z
SHA-256 of the archived text
7e01fe11b0734f06340d227a5d4816b102bb0133d16f280c709f65172b64b563
Stable URL of this page
https://metraipolis.com/documento/dc_df56ed40e5ab

How to cite

Nafamostat mesilate attenuates renal fibrosis by suppressing the IL-17 signaling pathway — Europe PMC PMID:41244830 — Europe PMC (en), https://europepmc.org/article/MED/41244830 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_df56ed40e5ab (Metraipolis archive dc_df56ed40e5ab, sha256 7e01fe11b0734f06340d227a5d4816b102bb0133d16f280c709f65172b64b563)
BibTeX
@misc{dcdf56ed40e5ab,
  title = {Nafamostat mesilate attenuates renal fibrosis by suppressing the IL-17 signaling pathway — Europe PMC PMID:41244830},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41244830},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_df56ed40e5ab; sha256 7e01fe11b0734f06340d227a5d4816b102bb0133d16f280c709f65172b64b563},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41244830. Agents can read the archived copy with the MCP tool read_document.